Back to results
US 10,556,922 B2Granted
Crystalline and amorphous forms of 17-alpha-hydroxyprogesterone caproate
AssigneeAMAG Pharmaceuticals, Inc.
InventorMahmoud Mirmehrabi
Life of this patent
Estimating the term…
Abstract
The disclosure is in part directed to crystalline forms of 17-α-hydroxyprogesterone caproate and variants thereof.
Claims22
A crystalline form of 17-α-hydroxyprogesterone caproate characterized by a powder X-ray diffraction pattern having a characteristic peak in degrees 2θ at about 9.6, 12.2, and 18.3 and a differential scanning calorimetry endothermic peak at about 100-105° C.
A crystalline form of 17-α-hydroxyprogesterone caproate characterized by a powder X-ray diffraction pattern having a characteristic peak in degrees 2θ at about 9.6, 12.2, 13.9, 14.8, 15.4, 18.3, and 19.2.
Dependencies are inferred from the claim text.